SK4299A3 - A tablet contaning methanesulfonate of trovafloxacin - Google Patents
A tablet contaning methanesulfonate of trovafloxacin Download PDFInfo
- Publication number
- SK4299A3 SK4299A3 SK42-99A SK4299A SK4299A3 SK 4299 A3 SK4299 A3 SK 4299A3 SK 4299 A SK4299 A SK 4299A SK 4299 A3 SK4299 A3 SK 4299A3
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- weight
- microcrystalline cellulose
- trovafloxacin
- methanesulfonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7201398P | 1998-01-21 | 1998-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK4299A3 true SK4299A3 (en) | 2000-06-12 |
Family
ID=22105016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK42-99A SK4299A3 (en) | 1998-01-21 | 1999-01-14 | A tablet contaning methanesulfonate of trovafloxacin |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6187341B1 (fr) |
| EP (1) | EP0930068A3 (fr) |
| JP (1) | JPH11269072A (fr) |
| KR (1) | KR100314977B1 (fr) |
| CN (1) | CN1227743A (fr) |
| AP (1) | AP1094A (fr) |
| AR (1) | AR012780A1 (fr) |
| AU (1) | AU758381B2 (fr) |
| BG (1) | BG103106A (fr) |
| BR (1) | BR9900116A (fr) |
| CA (1) | CA2259698C (fr) |
| CO (1) | CO4810225A1 (fr) |
| DZ (1) | DZ2712A1 (fr) |
| EA (1) | EA003247B1 (fr) |
| GT (1) | GT199900004A (fr) |
| HR (1) | HRP990023A2 (fr) |
| HU (1) | HUP9900154A3 (fr) |
| ID (1) | ID23735A (fr) |
| IL (1) | IL128051A0 (fr) |
| IS (1) | IS4947A (fr) |
| MA (1) | MA24747A1 (fr) |
| NO (1) | NO990243L (fr) |
| NZ (1) | NZ333838A (fr) |
| OA (1) | OA10958A (fr) |
| PA (1) | PA8466701A1 (fr) |
| PE (1) | PE20000169A1 (fr) |
| PL (1) | PL330981A1 (fr) |
| SG (1) | SG70666A1 (fr) |
| SK (1) | SK4299A3 (fr) |
| TN (1) | TNSN99007A1 (fr) |
| TR (1) | TR199900089A2 (fr) |
| TW (1) | TW518224B (fr) |
| YU (1) | YU2399A (fr) |
| ZA (1) | ZA99393B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU745282B2 (en) * | 1998-11-10 | 2002-03-21 | Bayer Intellectual Property Gmbh | Pharmaceutical moxifloxacin preparation |
| EP1216058A2 (fr) * | 1999-09-20 | 2002-06-26 | Alza Corporation | Procede destine a reduire la transformation polymorphique d'un medicament |
| AU773218B2 (en) * | 1999-10-08 | 2004-05-20 | Debiopharm International Sa | Fab I inhibitors |
| FR2808441B1 (fr) * | 2000-05-04 | 2004-06-18 | Oreal | Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau |
| DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| DE60230934D1 (de) * | 2001-04-06 | 2009-03-05 | Affinium Pharm Inc | Fab-i-inhibitoren |
| EP1396263A1 (fr) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Compositions d'enrobage pour tablettes et caplets |
| JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ， インク． | ヘテロ環化合物、その製造方法および治療におけるその使用 |
| CN100415284C (zh) * | 2002-12-30 | 2008-09-03 | 毛友昌 | 六味木香片的制备方法 |
| CA2519429C (fr) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Compositions pharmaceutiques comportant des inhibiteurs de fab i et autres antibiotiques |
| EP1459739B1 (fr) * | 2003-03-19 | 2008-01-02 | The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Compositions pharmaceutiques non-hygroscopique contenant des acides carboxiliques quinilones non-hydratés |
| US8906413B2 (en) * | 2003-05-12 | 2014-12-09 | Supernus Pharmaceuticals, Inc. | Drug formulations having reduced abuse potential |
| US20050019397A1 (en) * | 2003-07-23 | 2005-01-27 | Jacobs Richard L. | Cellulosic fiber containing composition |
| WO2007053131A2 (fr) | 2004-06-04 | 2007-05-10 | Affinium Pharmaceuticals, Inc. | Agents thérapeutiques et méthodes pour les fabriquer et les utiliser |
| US9308176B2 (en) * | 2004-10-15 | 2016-04-12 | Supernus Pharmaceuticals, Inc | Less abusable pharmaceutical preparations |
| CA2632476A1 (fr) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Agents therapeutiques et ses procedes de fabrication et d'utilisation |
| CA2658506C (fr) | 2006-07-20 | 2016-01-26 | Affinium Pharmaceuticals, Inc. | Derives d'acrylamide en tant qu'inhibiteurs de fab 1 |
| WO2008098374A1 (fr) * | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Sels, promédicaments et polymorphes d'inhibiteurs de fab 1 |
| WO2013190384A1 (fr) | 2012-06-19 | 2013-12-27 | Affinium Pharmaceuticals, Inc. | Dérivés de type promédicament du (e)-n-méthyl-n-((3-méthylbenzofuran-2-yl) méthyl)-3-(7-oxo-5,6,7,8-tétrahydro-l,8-naphtyridin-3-yl)acrylamide |
| MX2018010254A (es) | 2016-02-26 | 2018-12-19 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones de pie diabetico. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5286754A (en) | 1986-01-21 | 1994-02-15 | Bayer Aktiengesellschaft | Pharmaceutical formulations of ciprofloxacin |
| DE3601566A1 (de) * | 1986-01-21 | 1987-07-23 | Bayer Ag | Pharmazeutische zubereitungen von ciprofloxacin |
| US4957554A (en) | 1989-08-16 | 1990-09-18 | Minnesota Mining And Manufacturing Company | Dimensionally-controlled ceramics |
| DE4120646A1 (de) | 1991-06-22 | 1992-12-24 | Bayer Ag | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
| KR100343909B1 (ko) * | 1995-08-29 | 2003-04-10 | 화이자 인코포레이티드 | 트로바플록사신의쯔비터이온형태 |
-
1999
- 1999-01-11 PA PA19998466701A patent/PA8466701A1/es unknown
- 1999-01-13 EP EP99300258A patent/EP0930068A3/fr not_active Withdrawn
- 1999-01-14 AP APAP/P/1999/001443A patent/AP1094A/en active
- 1999-01-14 TR TR1999/00089A patent/TR199900089A2/xx unknown
- 1999-01-14 SK SK42-99A patent/SK4299A3/sk unknown
- 1999-01-14 IL IL12805199A patent/IL128051A0/xx unknown
- 1999-01-15 PE PE1999000036A patent/PE20000169A1/es not_active Application Discontinuation
- 1999-01-15 ID IDP990036D patent/ID23735A/id unknown
- 1999-01-15 OA OA9900009A patent/OA10958A/en unknown
- 1999-01-15 MA MA25433A patent/MA24747A1/fr unknown
- 1999-01-15 GT GT199900004A patent/GT199900004A/es unknown
- 1999-01-19 AR ARP990100191A patent/AR012780A1/es not_active Application Discontinuation
- 1999-01-19 IS IS4947A patent/IS4947A/is unknown
- 1999-01-19 JP JP11010298A patent/JPH11269072A/ja active Pending
- 1999-01-19 CA CA002259698A patent/CA2259698C/fr not_active Expired - Fee Related
- 1999-01-19 BR BR9900116-0A patent/BR9900116A/pt not_active IP Right Cessation
- 1999-01-20 AU AU12173/99A patent/AU758381B2/en not_active Ceased
- 1999-01-20 DZ DZ990013A patent/DZ2712A1/fr active
- 1999-01-20 US US09/233,823 patent/US6187341B1/en not_active Expired - Fee Related
- 1999-01-20 TN TNTNSN99007A patent/TNSN99007A1/fr unknown
- 1999-01-20 ZA ZA9900393A patent/ZA99393B/xx unknown
- 1999-01-20 KR KR1019990001589A patent/KR100314977B1/ko not_active IP Right Cessation
- 1999-01-20 PL PL99330981A patent/PL330981A1/xx unknown
- 1999-01-20 HU HU9900154A patent/HUP9900154A3/hu unknown
- 1999-01-20 NZ NZ333838A patent/NZ333838A/xx unknown
- 1999-01-20 YU YU2399A patent/YU2399A/sh unknown
- 1999-01-20 SG SG1999000117A patent/SG70666A1/en unknown
- 1999-01-20 NO NO990243A patent/NO990243L/no not_active Application Discontinuation
- 1999-01-20 CN CN99101232A patent/CN1227743A/zh active Pending
- 1999-01-21 CO CO99003190A patent/CO4810225A1/es unknown
- 1999-01-21 TW TW088100897A patent/TW518224B/zh not_active IP Right Cessation
- 1999-01-21 HR HR60/072,013A patent/HRP990023A2/hr not_active Application Discontinuation
- 1999-01-21 EA EA199900046A patent/EA003247B1/ru not_active IP Right Cessation
- 1999-01-21 BG BG103106A patent/BG103106A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK4299A3 (en) | A tablet contaning methanesulfonate of trovafloxacin | |
| DE69825592T2 (de) | Filmbeschichtungen und filmbeschichtungszusammensetzungen auf der basis von dextrin | |
| DE60203461T2 (de) | Makrolidcitrat-haltige Formulierungen mit kontrollierter Freisetzung | |
| EP2029134B1 (fr) | Compositions pharmaceutiques stabilisées contenant de la fésotérodine | |
| KR101774676B1 (ko) | 히드로모르폰 및 날록손을 포함하는 제약 조성물 | |
| HU227397B1 (en) | Pharmaceutical formulations containing darifenacin | |
| NO321615B1 (no) | Farmasoytisk preparat for oral administrering av et N-piperidino-3-pyrazolkarboksyamidderivat, samt salter og solvater derav og fremgangsmate for fremstilling derav | |
| HUE026040T2 (en) | Formulations of SRC / ABL inhibitor | |
| US5968553A (en) | Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer | |
| EP1296685B1 (fr) | Preparations a liberation prolongee a base d'antibiotiques de type quinolones et procede d'elaboration desdites preparations | |
| DE60128263T2 (de) | Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung | |
| DE112006001853T5 (de) | Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten | |
| DE60026481T2 (de) | Wässriges filmbildendes Überzugsmittel und oral anzuwendende feste Arzneizubereitung | |
| PL181470B1 (pl) | Kompozycja o przedluzonym uwalnianiu cyzaprydu i sposób wytwarzania kompozycji o przedluzonym uwalnianiu cyzaprydu PL PL PL PL PL PL PL PL PL PL | |
| EP1928441B1 (fr) | Formulation à effet retard comprenant du 3-(2-diméthyleaminométhylecyclohexyle)phenol | |
| CZ9399A3 (cs) | Tableta obsahující methansulfonát trovafloxacinu | |
| CN112641744B (zh) | 一种交沙霉素薄膜衣片及其制备方法 | |
| DE202020106805U1 (de) | Dosierungsformen mit verlängerter Freisetzung von Tapentadol-Phosphorsäuresalz | |
| DE10353832A1 (de) | Feste pharmazeutische Zubereitungsform | |
| DE202020103814U1 (de) | Dosierungsformen mit verlängerter Freisetzung von Tapentadol-Phosphorsäuresalz |